Fig. 2 Fluorescence emission spectra for tryptophan derivatives 3a
and 4 in water (c = 100 mM unless otherwise indicated).
Fig. 1 Fluorescence emission spectra for tryptophan and derivatives
3a, 3c, 3d and 4 in methanol (3a, 3d, 4: c = 100 mM; 3c: c = 10 mM).
fully to the modification of a dipeptide, potentially opening the
door towards the direct cross-coupling of larger peptides and even
proteins. The cross-coupling products described herein possess
interesting fluorescent properties. Individual analogues showed
strong fluorescence emission in water and at lex 295 nm, and may
therefore be particularly useful for the site-selective, fluores-
cent labelling of peptides, proteins and natural products.
Financial support by the Leverhulme Trust (F/00 204/AF,
to RJMG), BBSRC (BBE0089841) and the EPSRC (First
Grant EP/D059186/1, to GKW) is gratefully acknowledged.
We thank Thomas Pesnot for the synthesis of TXPTS, and the
EPSRC National Mass Spectrometry Service Centre,
Swansea, for the recording of mass spectra.
Table 3 Fluorescence spectroscopic properties of tryptophan analogues
Compound
Solvent
lex/nm
lem/nm
Stokes shifta/cmꢂ1
Trp
3a
3a
3c
3c
3d
3d
4
MeOH
MeOH
Water
MeOH
Water
MeOH
Water
MeOH
Water
280
254
254
254
254
254
254
254
254
348
370
395
353
357
411
443
375
384
6978
12 343
14 054
11 041
11 359
15 039
16 797
12 703
13 328
4
a
Stokes shift = (1/lex ꢂ 1/lem).
largest Stokes shift observed in this series. Interestingly,
7-phenyltryptophan 4 was less strongly fluorescent than its
regioisomer 3a, with a fluorescence intensity comparable to
tryptophan itself but, once again, a larger Stokes shift.
Notes and references
1 (a) G. D. Rose, A. R. Geselowitz, G. J. Lesser, R. H. Lee and M.
H. Zehfus, Science, 1985, 229, 834; (b) D. A. Dougherty, Science,
1996, 271, 163.
2 (a) A. Aitken and M. Learmonth, Quantitation of tryptophan in
proteins, in Protein Protocols Handbook, ed. J. M. Walker,
Humana Press, New York, 2002, pp. 41–44; (b) P. R. Callis and
T. Liu, J. Phys. Chem. B, 2004, 108, 4248.
3 (a) D. R. Dalton, The Alkaloids, Marcel Dekker, New York, 1979,
p. 415; (b) C. Kempter, D. Kaiser, S. Haag, G. Nicholson, V.
Gnau, T. Walk, K. H. Gierling, H. Decker, H. Zahner, G. Jung
and J. W. Metzger, Angew. Chem., Int. Ed. Engl., 1997, 36, 498.
4 E. Yeh, S. Garneau and C. T. Walsh, Proc. Natl. Acad. Sci. U. S.
A., 2005, 102, 3960.
With a view towards potential biological applications, we
also measured the fluorescence of selected aryl tryptophans
in water and at lex 4 254 nm, in order to minimise, in a
biological context, concomitant excitation of standard organic
fragments (Fig. S1–S3w).w Pleasingly, tryptophan derivatives
3a, 3c and 4 were strongly fluorescent in water at an excitation
wavelength of 254 nm (Fig. S1w). Compared to measurements
in methanol, all analogues showed moderately or significantly
increased Stokes shifts in water (Table 3). Importantly, at lex
295 nm most aryltryptophans were still significantly more
fluorescent than the parent tryptophan (Fig. S2 and S3w).
While the 5-phenyltryptophan derivatives 3a and 3c exhibited
a reduced fluorescence intensity at lex 295 nm, the intensity of
the fluorescence signal of 7-phenyltryptophan 4 did increase
slightly with the longer excitation wavelength (Fig. 2), making
this analogue particularly interesting for further development.
Taken together, these results show that the fluorescence of
aryltryptophans can be modulated by the choice of substituent
and regiochemistry. This flexibility will allow the design of
tryptophan derivatives with spectrophotometric properties
tailored specifically to individual target peptides and proteins.
In conclusion, we have identified suitable conditions for the
Suzuki–Miyaura cross-coupling of unprotected 5- and 7-halo-
tryptophans with a variety of boronic acids. All cross-coupling
reactions were carried out in water, with generally short reaction
times. Importantly, these conditions could also be applied success-
5 N. Lindquist, W. Fenical, C. D. Van Duyne and J. Clardy, J. Am.
Chem. Soc., 1991, 113, 2303.
6 (a) K. H. Shaughnessy and R. B. DeVasher, Curr. Org. Chem., 2005,
9, 585; (b) K. H. Shaughnessy, Eur. J. Org. Chem., 2006, 8, 1827.
7 (a) Y. Gong and W. He, Org. Lett., 2002, 4, 3803; (b) P. Capek, R.
Pohl and M. Hocek, Org. Biomol. Chem., 2006, 4, 2278.
8 (a) W. Wang, C. Xiong, J. Zhang and V. J. Hruby, Tetrahedron,
2002, 58, 3101; (b) M. Kaiser, M. Groll, C. Renner, R. Huber and
L. Moroder, Angew. Chem., Int. Ed., 2002, 41, 780; (c) N. Basse, S.
Piguel, D. Papapostolou, A. Ferrier-Berthelot, N. Richy, M.
Pagano, P. Sarthou, J. Sobczak-Thepot, M. Reboud-Ravaux, J.
Vidal and Joeelle, J. Med. Chem., 2007, 50, 2842.
9 R. J. M. Goss and P. L. A. Newill, Chem. Commun., 2006, 4924.
10 D. G. Fujimori and C. T. Walsh, Curr. Opin. Chem. Biol., 2007, 11,
553, and references therein.
11 E. C. Western, J. R. Daft, E. M. Johnson, P. M. Gannett and K. H.
Shaughnessy, J. Org. Chem., 2003, 68, 6767.
12 (a) A. Collier and G. K. Wagner, Org. Biomol. Chem., 2006, 4,
4526; (b) P. Capek, H. Cahova, R. Pohl, M. Hocek, C. Gloeckner
and A. Marx, Chem.–Eur. J., 2007, 13, 6196.
13 A. Collier and G. K. Wagner, Chem. Commun., 2008, 178.
14 H. Gulyas, A. Szollosy, B. E. Hanson and J. Bakos, Tetrahedron
´
Lett., 2002, 43, 2543.
ꢀc
This journal is The Royal Society of Chemistry 2008
Chem. Commun., 2008, 4831–4833 | 4833